文献速递中医内科中药与中成药合理使用

中药灌肠治疗溃疡性结肠炎的有效性与安全性:基于证据的系统评价

Clinical Effectiveness and Safety of Chinese Herbal Enema for Ulcerative Colitis: An Evidence-Based Study.
PubMed 文献 · Am J Chin Med · 2026-01-26

本研究系统检索截至2025年4月19日的随机对照试验,采用网络Meta分析评估中药灌肠治疗溃疡性结肠炎的疗效与安全性。共纳入41项RCT、2883例患者,结果显示与美沙拉嗪单药相比,美沙拉嗪联合青白灌肠液或青赤散,以及黄葵连肠汤、白头翁汤单药,在临床结局上均有统计学显著改善。疗效受中医辨证分型和疾病严重程度影响,支持个体化分层治疗。

要点

  • 中药灌肠治疗溃疡性结肠炎可能临床有效且安全
  • 美沙拉嗪联合青白灌肠液或青赤散较单药有显著改善
  • 黄葵连肠汤、白头翁汤单药也显示统计学显著改善

核心结论

  • 中药灌肠治疗溃疡性结肠炎在临床上似乎有效且安全,支持分层中医治疗和溃疡性结肠炎治疗指南的完善。

研究设计与样本

  • 系统检索截至2025年4月19日发表的评估中药灌肠治疗溃疡性结肠炎的随机对照试验,最终纳入41项RCT、共2883例溃疡性结肠炎患者,采用Stata 17.0进行网络Meta分析,效应量以均数差或相对危险度及相应95%置信区间报告,并报告了偏倚风险评估数据。

主要发现

  • 与美沙拉嗪单药治疗相比,美沙拉嗪联合青白灌肠液或美沙拉嗪联合青赤散等联合疗法,以及黄葵连肠汤和白头翁汤等单药疗法,在临床结局上均显示统计学显著改善。
  • 亚组分析显示,这些干预措施的临床有效性受中医辨证分型和疾病严重程度影响,凸显了个体化分层治疗的重要性。

临床怎么用

  • 对于溃疡性结肠炎患者,可考虑在美沙拉嗪基础上联合青白灌肠液或青赤散,或根据辨证选用黄葵连肠汤、白头翁汤单药灌肠,并应结合中医辨证分型和疾病严重程度进行个体化分层治疗。

局限性

  • 未来需要优先开展高质量、大样本的随机对照试验来验证这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ulcerative colitis (UC) is a common, chronic, and nonspecific inflammatory bowel disease which significantly impair patients' quality of life, and is characterized by a prolonged disease course and frequent relapses. Due to their localized therapeutic action and low incidence of adverse effects, Chinese herbal enemas have garnered increasing attention in clinical settings. This study aims to systematically evaluate the therapeutic potential of Chinese herbal enemas in UC management. Randomized controlled trials (RCTs) evaluating Chinese herbal enemas for UC, published up to April 19, 2025, were systematically searched. A network meta-analysis was performed using Stata 17.0, and the combined effect sizes were reported as the mean difference or relative risk with corresponding 95% confidence intervals. A total of 41 RCTs involving 2883 UC patients were ultimately included, and data on the risk of bias assessment were reported. When compared with mesalazine (MES) monotherapy, combination therapies, such as MES combined with Qingbai Guanchang Ye or MES combined with Qingchi San, and monotherapies including Huangkui Lianchang Tang and Baitouweng Tang, demonstrated statistically significant improvements in clinical outcomes. Subgroup analyses were also conducted. The clinical effectiveness of these interventions was also influenced by Traditional Chinese Medicine (TCM) syndrome differentiation and disease severity, which underscores the importance of individualized, stratified treatment approaches. Our study data showed that Chinese herbal enema therapy appears to be both clinically effective and safe in the management of UC, and supported both stratified TCM therapy and the refinement of UC treatment guidelines. Future research is needed to prioritize high-quality, large-scale RCTs to validate these findings.

来源:Am J Chin Med,查看原文。版权归原作者所有。

引用

  1. Bu Z, Chong J, Ma J, et al. Clinical Effectiveness and Safety of Chinese Herbal Enema for Ulcerative Colitis: An Evidence-Based Study. Am J Chin Med. 2026. PMID: 41582082. doi:10.1142/S0192415X26500047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。